. Electroretinogram traces for adult subjects. Subject ID is given on the left for each trace. DA refers to Dark Adapted; LA to Light Adapted; PERG to Pattern ERG. Supp. Table S1 provides further details.
Supp. Figure S3 . Distribution of electroretinogram amplitudes by mutation class and patient. Full-field ERG amplitudes in 10 patients. Amplitudes are expressed as a percentage of the age-matched lower limit of normal and are shown for dark-adapted ERGs (DA0.01; DA010.0 a-wave) and light adapted ERGs (LA 3.0 30Hz; LA 3.0 b-wave). The genotype is stated for each subject. Lower limit of normal is defined as the minimum normal value minus 5% of the reference interval (maximum-minimum normal value in a group of healthy subjects). Figure S4 . Electroretinogram (ERG) amplitudes and patient age.
Comparison of full-field ERG amplitudes (DA 10.0 ERG a-wave; LA 3.0 30Hz ERG) with age in 6 individuals with exon 3 interchange haplotypes. There is a trend for ERG amplitudes (corrected for age) to decrease with advancing age.
Supp. Figure S5 . Serial electroretinograms (ERG) of patients S21 and S26. Comparison of fullfield ERG parameters at baseline with those at follow-up in S21 and S26. In S21 DA 0.01 and DA 10.0 a-wave amplitudes showed marked reduction in amplitude after 12 years. In S26 all amplitudes were reasonably stable but DA0.01 ERG showed an increase in peak time of 15ms bilaterally after an interval of 5 years.
Supp. Figure S6 . Splicing motif prediction comparison for wild-type and disease associated L-and M-exon 3 haplotypes. (A) Splice enhancer motifs (yellow type) predicted by RESCUE-ESE are shown above the genomic sequence of exon 3 for each haplotype (shown to left of figure) . The SNP c.532A>G results in loss of a splice enhancer motif (white arrow) in all 3 disease associated haplotypes LIAVA, LVAVA and MIAVA. (B) Splice silencer motifs (red type) predicted by FAS-ESS are shown above exon 3 genomic sequence. SNP c.532A>G results in the gain of a splice silencer motif (black arrow) in all three disease associated haplotypes while other SNPs in the haplotype have no predicted effect on splicing.
Supp. 
